Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressant exposure during pregnancy and breastfeeding
2012-004509-29Phase 4Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of citalopram, escitalopram, sertraline, paroxetine, fluvoxamine and 3 more in major depressive disorder (MDD) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Average and variability in plasma and milk concentrations of SSRI/SNRI. Started Sep 2015; status: completed.
02
Drugs
citalopramescitalopramsertralineparoxetinefluvoxamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2012-004509-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004509-29.